ライフサイエンスコーパス: suicidal

1 behavior in persons who were not known to be suicidal.

2 itivity to bodily signals is associated with suicidal action by comparing individuals with a history

3 pends on the distribution of methods used in suicidal acts and the probability of death given a parti

4 Results are based on suicidal acts resulting in an ED visit, a hospitalizatio

5 e case-fatality rate (CFR)-the proportion of suicidal acts that are fatal-depends on the distribution

6 Overall, 8.5% of suicidal acts were fatal (14.7% for males vs. 3.3% for f

7 rearms were the most lethal method (89.6% of suicidal acts with a firearm resulted in death), followe

8 ained by the distribution of methods used in suicidal acts.

9 controlled-release zolpidem (zolpidem-CR) in suicidal adults with insomnia would provide a reduction

10 ded to operate suicidally, may be capable of suicidal and - in hypoxic conditions - nonsuicidal opera

11 specific elements of suicide risk including suicidal and death-related thoughts, hopelessness, restl

12 mprove the management of individuals who are suicidal and decrease suicide-associated morbidity.

13 controversy exists about the degree to which suicidal and non-suicidal self-harm share a common genet

14 No systematic differences emerged between suicidal and non-suicidal self-harm.

15 Together, suicidal and nonsuicidal behaviors are related to top-do

16 r, the genetic aetiology of broad sense (non-suicidal and suicidal) self-harm has not been characteri

17 Our findings have parallels to the suicidal attacks of social insects [6-9], which are also

18 t behaviours, including pre-emptive attacks, suicidal attacks, and reciprocation (tit-for-tat).

19 dings possibly suggest that vulnerability to suicidal attempt can be derived from suicidal ideation c

20 We documented one case of suicidal attempt in a woman following HIV seroconversion

21 and supplemented comparison with and without suicidal attempt.

22 l ideations; or MDD patients with or without suicidal attempt.

23 ior exposure to suicide, suicide attempt, or suicidal behavior (composite measure-suicide or suicide

24 By contrast, exposure to suicidal behavior (composite) was associated with increa

25 19, from 13 independent studies; exposure to suicidal behavior (composite): k = 10, from 5 independen

26 isits were used to predict future documented suicidal behavior (i.e., suicide attempt or death).

27 as observed in individuals with a history of suicidal behavior (MRR = 1.28, 95% CI = 1.07-1.54) and i

28 Suicidal behavior (SB) can be impulsive or methodical; v

29 linked to worse disease course and increased suicidal behavior across disorders.

30 a major risk factor for major depression and suicidal behavior along with other psychiatric illnesses

31 We aimed to quantify the risk of suicidal behavior in a large nationwide cohort of patien

32 Family studies have shown an aggregation of suicidal behavior in families.

33 rare cases may lead to suicidal ideation or suicidal behavior in persons who were not known to be su

34 r mechanism responsible for the high rate of suicidal behavior in SCZ remains poorly understood.

35 ese studies focused on the susceptibility of suicidal behavior in SCZ.

36 Predictors of suicidal behavior in the TD/CTD cohort were studied usin

37 risk and protective factors associated with suicidal behavior in this group.

38 Here we tested the hypothesis that suicidal behavior is associated with heightened aversion

39 Suicidal behavior is associated with impaired decision m

40 Serious suicidal behavior is associated with impaired reward lea

41 The ability to identify risk factors for suicidal behavior is critical to selected and indicated

42 ctions from these findings to depression and suicidal behavior later in life.

43 Exposure to suicidal behavior may be associated with increased risk

44 Accurately predicting suicidal behavior remains challenging.

45 havior, but the effect of ADHD medication on suicidal behavior remains unclear.

46 Suicidal behavior should be monitored in these patients,

47 ar disorder is associated with high risk for suicidal behavior that often develops in adolescence and

48 ICD-9-based case definition for suicidal behavior was derived by expert clinician consen

49 ctivity disorder (ADHD) is a risk factor for suicidal behavior, but the effect of ADHD medication on

50 associated with increased odds of subsequent suicidal behavior, but these exposures do not incur unif

51 gical, and personality disorders, as well as suicidal behavior, memory loss, and urinary syndromes; t

52 Suicidal behavior, which has been associated with high Q

53 rietal connectivity in impulsive people with suicidal behavior, which may underlie disrupted choice p

54 ors to the familial coaggregation of OCD and suicidal behavior.

55 can be useful for predicting future risk of suicidal behavior.

56 e on average) prediction of patients' future suicidal behavior.

57 ch has been linked to the pathophysiology of suicidal behavior.

58 be used to predict patients' future risk of suicidal behavior.

59 e conditions should be closely monitored for suicidal behavior.

60 ely support disrupted vmPFC value signals in suicidal behavior.

61 ing and after the ED visit decreased post-ED suicidal behavior.

62 ED-initiated intervention reduces subsequent suicidal behavior.

63 ic disorders, including problem gambling and suicidal behavior.

64 es are critical in developing depression and suicidal behavior.

65 alternative to lithium, are inconsistent for suicidal behavior.

66 ish national registry data for prediction of suicidal behavior.

67 at collectively showed the complex nature of suicidal behavior.

68 1.2% (N=20,246) met the case definition for suicidal behavior.

69 disrupting cellular pathways associated with suicidal behavior.

70 ding schizophrenia and psychotic illness and suicidal behavior.

71 ng in depressed individuals with and without suicidal behavior.

72 nto single composite measures of exposure to suicidal behavior.

73 t blunted interoception may be implicated in suicidal behavior.

74 ons and the pathophysiological mechanisms of suicidal behavior.

75 nce links infections to mental disorders and suicidal behavior.

76 s have estimated substantial heritability of suicidal behavior; however, collecting the sample sizes

77 e associations between opioid use/misuse and suicidal behaviors and propensity score-weighted logisti

78 It is yet unknown whether OCD and suicidal behaviors coaggregate in families and, if so, w

79 ly, these observations indicate that OCD and suicidal behaviors coaggregate in families largely due t

80 relationship between medical opioid use and suicidal behaviors is not known.

81 redictors of the emergence of depressive and suicidal behaviors throughout life.

82 id misuse is associated with greater odds of suicidal behaviors, but opioid use without misuse is not

83 shown associations between opioid misuse and suicidal behaviors, but the relationship between medical

84 incidence rate ratio, 2.0; 95% CI, 1.9-2.2), suicidal behaviors, mortality, and municipal support.

85 ersons without misuse have a reduced risk of suicidal behaviors.

86 l illness onset, treatment non-response, and suicidal behaviors.

87 ay provide targets for reducing the risks of suicidal behaviors.

88 < 0.001), and lower likelihood of reporting suicidal behaviour (aPR = 0.71; 95% CI 0.51, 1.01; p = 0

89 ey included 30,030 individuals with nonfatal suicidal behaviour and 4,996 individuals who had died by

90 ted rates of childhood trauma, self-harm and suicidal behaviour and ideation (SSBI).

91 Suicide and suicidal behaviour continue to present key challenges fo

92 CI 30%-61%) of those who engaged in nonfatal suicidal behaviour had a psychiatric disorder.

93 lower prevalence of psychiatric disorders in suicidal behaviour in LMIC.

94 of psychiatric morbidity in individuals with suicidal behaviour in LMIC.

95 Clustering of suicidal behaviour is more common in young people (<25 y

96 transmission and the media), perception that suicidal behaviour is widespread, susceptible young peop

97 revalent disorder in both fatal and nonfatal suicidal behaviour was mood disorder (25% and 21%, respe

98 d depression, violence experience and recent suicidal behaviour, alcohol use and recent suicidal beha

99 g likely to socialise with others at risk of suicidal behaviour, and social cohesion contributing to

100 In nonfatal suicidal behaviour, anxiety disorders, and substance mis

101 t suicidal behaviour, alcohol use and recent suicidal behaviour, illicit drug use and depression, dep

102 ect on Patient Health Questionnaire 9 score, suicidal behaviour, percentage of days of heavy drinking

103 ences of providing care for individuals with suicidal behaviour, published in English or a Scandinavi

104 3% and 86% in those who engaged in nonfatal suicidal behaviour.

105 n the prevalence of psychiatric morbidity in suicidal behaviour.

106 , post-traumatic stress disorder (PTSD), and suicidal behaviour.

107 7% (3%-11%) of those who engaged in nonfatal suicidal behaviour.

108 e community requires real-time monitoring of suicidal behaviour.

109 ve particularly important roles in spreading suicidal behaviour.

110 ta signalling pathway in the pathogenesis of suicidal behaviour.

111 of providing care for individuals displaying suicidal behaviour.

112 everal independent markers and predictors of suicidal behaviours converging to this increased risk.

113 Given the low base rate of suicidal behaviours, our findings raise questions about

114 We identified 116 articles discussing SI, suicidal behaviours, suicide attempts and/or fatal suici

115 ase-mediated mitochondrial damage leading to suicidal cell death.

116 may underlie disrupted choice processes in a suicidal crisis.

117 Suicidal depressed (SD) patients, non-suicidal depressed (NSD) patients, and HCs significantly

118 Suicidal depressed (SD) patients, non-suicidal depressed

119 , 874-1467) and among patients admitted with suicidal ideas or behaviors (2078; 95% CI, 1512-2856).

120 MDD (odds ratio 1.98, 95% CI 1.11-3.53) and suicidal ideation (2.47, 1.19-5.10) compared with their

121 equently falls (n=5), suicide attempt (n=4), suicidal ideation (n=3), head injury (n=3), and aspirati

122 out misuse was associated with lower odds of suicidal ideation (odds ratio (OR) = 0.57, 95% confidenc

123 , 1.53; 95% confidence interval, 1.15-2.02), suicidal ideation (odds ratio, 1.27; 95% confidence inte

124 and no use was associated with lower odds of suicidal ideation (OR = 0.62, 95% CI: 0.49, 0.80), suici

125 tudinal association between irritability and suicidal ideation (SI) in adults with major depressive d

126 D (n = 29) and MDD (n = 29) as a function of suicidal ideation (SI) to compare with that of healthy c

127 have many known risk factors for suicide and suicidal ideation (SI).

128 e disorder and a score >/=4 on the Scale for Suicidal Ideation (SSI), of whom 54% (N=43) were taking

129 GRIK2 (which likely play a role in emergent suicidal ideation after antidepressant treatment), GRIK4

130 derstanding of the epidemiological impact of suicidal ideation after stroke is required to identify s

131 and early interventions to prevent and treat suicidal ideation after stroke, especially among subject

132 The pooled proportion of suicidal ideation among stroke survivors was 11.8% (7.4%

133 ysis was to estimate rates and correlates of suicidal ideation among stroke survivors.

134 onnectivity in 46 patients with MDD (23 with suicidal ideation and 23 without) and 36 age- and gender

135 structures in 48 patients with MDD (24 with suicidal ideation and 24 without) and 25 age- and sex-ma

136 nectivity may be associated with severity of suicidal ideation and attempt lethality.

137 reater comorbidities, and increased risk for suicidal ideation and attempts in individuals with mood

138 onpharmacologic approaches for patients with suicidal ideation and behavior.

139 en right rostral prefrontal connectivity and suicidal ideation and between left ventral prefrontal co

140 subjects, and had an increased prevalence of suicidal ideation and depressive symptoms.

141 he intervention decreases the probability of suicidal ideation and hazardous drinking in adolescence

142 e (1%) participant in the the placebo group, suicidal ideation and intentional overdose in one (1%) p

143 reased risk of suicide, suicide attempt, and suicidal ideation and is a significant public health pro

144 few studies have focused on the severity of suicidal ideation and its association with subcortical a

145 tal health, using measures of overweight and suicidal ideation and planning which some have shown to

146 psychiatric outcomes (depression, PTSD, and suicidal ideation and/or self-harm) were scored by inter

147 Depression, anxiety, and suicidal ideation are more common among AD individuals,

148 ajor depressive disorder (MDD) patients with suicidal ideation are poorly understood.

149 analysis included only participants who had suicidal ideation at baseline (N=167).

150 Predefined outcomes were (1) rates of suicidal ideation based on random-effects pooled proport

151 lity to suicidal attempt can be derived from suicidal ideation combined with depression and impulsivi

152 BT and DBT showed modest benefit in reducing suicidal ideation compared with TAU or wait-list control

153 t dialectical behavior therapy (DBT) reduces suicidal ideation compared with wait-list control or cri

154 Suicidal ideation due to abortion has been used to justi

155 Depression and suicidal ideation improved equally with both formats.

156 iption of hypnotic medication for mitigating suicidal ideation in all depressed outpatients with inso

157 greater reduction in clinically significant suicidal ideation in depressed patients within 24 hours

158 Pharmacotherapy to rapidly relieve suicidal ideation in depression may reduce suicide risk.

159 ETATION: The increased likelihood of MDD and suicidal ideation in frequent cannabis users cannot be s

160 This study investigated specific changes of suicidal ideation in functional connectivity of MDD pati

161 eft orbitofrontal-both thalamic regions with suicidal ideation in MDD were inversely proportional to

162 travenous ketamine on clinically significant suicidal ideation in patients with major depressive diso

163 he outcomes of suicide, suicide attempt, and suicidal ideation in relatives, friends, and acquaintanc

164 ead to very high risk circumstances in which suicidal ideation is converted to lethal actions via dec

165 The advantage for zolpidem-CR in reducing suicidal ideation on the C-SSRS was greater in patients

166 Of all respondents, 62% had a history of suicidal ideation or attempt according to the petitioner

167 egimens; suicidality was defined as reported suicidal ideation or attempted or completed suicide.

168 There was no evidence of increased suicidal ideation or behavior.

169 a-analysis was not feasible for wellbeing or suicidal ideation or self-harm outcomes, and results are

170 parasomnias, which in rare cases may lead to suicidal ideation or suicidal behavior in persons who we

171 evidence of an association was observed for suicidal ideation outcomes (2 studies, N = 43,354; OR =

172 ide attempt on suicide, suicide attempt, and suicidal ideation outcomes and to identify moderators of

173 The prevalence of suicidal ideation ranged from 1102 (24.9%) of 4432 peopl

174 Ketamine's effect on suicidal ideation remained significant after adjusting f

175 Ketamine rapidly (within 1 day) reduced suicidal ideation significantly on both the clinician-ad

176 s with insomnia would provide a reduction in suicidal ideation superior to placebo.

177 Reducing Suicidal Ideation Through Insomnia Treatment was an 8-we

178 crease the probability of transitioning from suicidal ideation to action.

179 Moreover, suicidal ideation was less likely in stroke survivors wh

180 Suicidal ideation was not significantly associated with

181 Suicidal ideation was the main outcome, measured first b

182 atios (ORs) of suicide, suicide attempt, and suicidal ideation were analyzed using multilevel meta-an

183 Ketamine's effects on suicidal ideation were partially independent of its effe

184 ic treatments suggests that ketamine reduces suicidal ideation with minimal adverse events compared w

185 We examined overweight/obesity and suicidal ideation with planning by gross domestic produc

186 erweight/obesity was positively related with suicidal ideation with planning for girls (odds ratio (O

187 and 7.5% of boys and 17.5% of girls reported suicidal ideation with planning over the last 12 months.

188 In contrast to overweight/obesity status, suicidal ideation with planning was not related to macro

189 tatus, and 59,061 adolescents reported about suicidal ideation with planning.

190 h adolescent overweight/obesity but not with suicidal ideation with planning.

191 d a statistically nonsignificant increase in suicidal ideation with venlafaxine.

192 th mental illness had a higher prevalence of suicidal ideation within the first year after surgery (n

193 hypothesized that structures associated with suicidal ideation would be derived from a combination of

194 compare prevalences of depression, anxiety, suicidal ideation, and anxiety attacks, in adults with a

195 oral therapy (CBT) reduces suicide attempts, suicidal ideation, and hopelessness compared with treatm

196 5D visual analogue scale, sociodemographics, suicidal ideation, and stress (negative life events and

197 positive internal states that can stimulate suicidal ideation, and that impairments in a DPFC and in

198 ssion, atopic dermatitis was associated with suicidal ideation, and that parental emotional support m

199 the overall effects of sleep disturbances on suicidal ideation, attempts, and death.

200 Although pain and suicidality (including suicidal ideation, behaviour, and death by suicide) both

201 ls with depression, and its association with suicidal ideation, needs further clarification.

202 lf-report anxiety and depression, wellbeing, suicidal ideation, or self-harm.

203 haviors that precede these deaths, including suicidal ideation, suicide attempts, hazardous drinking,

204 d associations of opioid use and misuse with suicidal ideation, suicide plans, and suicide attempts a

205 al factors and suicide, suicide attempt, and suicidal ideation.

206 ith major depressive disorder, insomnia, and suicidal ideation.

207 ssociated with suicide, suicide attempt, and suicidal ideation.

208 verity of suicidal risk in MDD patients with suicidal ideation.

209 about one out of eight stroke survivors has suicidal ideation.

210 information integration in MDD patients with suicidal ideation.

211 antly negatively correlated with severity of suicidal ideation.

212 hat hypnotic medications are associated with suicidal ideation.

213 mate, suggesting a possible association with suicidal ideation.

214 for up to 1 week in depressed patients with suicidal ideation.

215 (SMD=-0.22; p=0.03) were all associated with suicidal ideation.

216 rm that ketamine exerts a specific effect on suicidal ideation.

217 Analyses yielded similar results examining suicidal ideation.

218 r income-and subsequent suicide attempts and suicidal ideation.

219 No changes in mood or self-reports of suicidal ideation/behavior were observed.

220 ignificantly predicted depression, PTSD, and suicidal ideation/self-harm and explained up to 0.6% of

221 genetic influences on depression, PTSD, and suicidal ideation/self-harm are at least partially share

222 ere present in MDD patients with and without suicidal ideation; and supplemented comparison with and

223 ations were observed for suicide attempt and suicidal ideation; however, these results were based on

224 volume between MDD patients with or without suicidal ideations; or MDD patients with or without suic

225 ression (lifetime self-harm with and without suicidal intent at age 21 years).

226 (ie, on at least one previous occasion) with suicidal intent than heterosexuals.

227 .e. any lifetime self-harm act regardless of suicidal intent) using data from the UK Biobank (n > 156

228 t associated with sexual arousal and without suicidal intent.

229 atients with bipolar disorder with suspected suicidal intentions, although risk for suicide is only o

230 re we show that miropin uses the serpin-type suicidal mechanism.

231 neurodegenerative disorder with accelerated suicidal neuronal cell death, which could be reversed by

232 hesizes MVT de novo via a novel route, via a suicidal or a nonsuicidal THI4, or by catabolizing thiam

233 criteria included if the patient was acutely suicidal or had a psychiatric condition that affected th

234 Exclusion criteria consisted of suicidal or homicidal intent or psychosis.

235 on of an antidepressant may be beneficial in suicidal outpatients, especially in patients with severe

236 TRH), a water soluble drug used for treating suicidal patients, was incorporated into a fast degradin

237 ent for anxiety or depression, presence of a suicidal plan, bipolar disorder, psychosis, posttraumati

238 The prevalence of increased suicidal risk (defined as moderate to high risk suicidal

239 er gene and their association with increased suicidal risk among human immunodeficiency virus (HIV)-p

240 PR was found to be associated with increased suicidal risk before Bonferroni correction (p-value = 0.

241 we found that pain approximately doubles the suicidal risk in adolescents, with a few studies suggest

242 owed a positive correlation with severity of suicidal risk in MDD patients with suicidal ideation.

243 een implicated in the aetiology of increased suicidal risk in non-HIV infected study populations and

244 intervention strategies aimed to reduce the suicidal risk in this group are warranted.

245 Increased suicidal risk is a predictor of future attempted and com

246 adults suggest that pain can exacerbate the suicidal risk of an individual.

247 A protective effect on increased suicidal risk was found for the 5-HTTLPR/rs25531 S A all

248 sts there are biological features related to suicidal risk, including brain morphometric features, le

249 ded to ketamine infusion but have a residual suicidal risk.

250 erse events were reported, all of which were suicidal risks detected during screening.

251 treatment during IVF-these receptors act as 'suicidal' segregation distorters that impair their own t

252 ct suicide attempt, suicide thoughts and non-suicidal self-harm (NSSH) in an independent target sampl

253 lso unknown is whether the prevalence of non-suicidal self-harm (NSSH) or suicidal self-harm, or both

254 redictors of transition to attempts were non-suicidal self-harm (odds ratio [OR] 2.78, 95% CI 1.35-5.

255 Suicidal thoughts and non-suicidal self-harm are common in adolescents and are str

256 d suicidal thoughts and 569 who reported non-suicidal self-harm at 16 years of age.

257 Among participants with non-suicidal self-harm at baseline, the strongest predictors

258 ) of 380 participants who had engaged in non-suicidal self-harm reported having attempted suicide for

259 s about the degree to which suicidal and non-suicidal self-harm share a common genetic aetiology.

260 nts who think about suicide or engage in non-suicidal self-harm will not make an attempt on their lif

261 evalence of non-suicidal self-harm (NSSH) or suicidal self-harm, or both, has increased.

262 suggest that asking about substance use, non-suicidal self-harm, sleep, personality traits, and expos

263 differences emerged between suicidal and non-suicidal self-harm.

264 pes, we found stronger associations with non-suicidal self-injury in non-clinical samples.

265 Non-suicidal self-injury is being increasingly recognised as

266 ing of childhood maltreatment history in non-suicidal self-injury risk assessments might hold particu

267 l abuse and neglect) in association with non-suicidal self-injury.

268 ent and its subtypes are associated with non-suicidal self-injury.

269 ng its specific subtypes, in relation to non-suicidal self-injury.

270 c aetiology of broad sense (non-suicidal and suicidal) self-harm has not been characterised on the mo

271 ata point to two natural alternatives to the suicidal THI4 pathway: (i) nonsuicidal prokaryotic THI4s

272 TSPO was not elevated in patients without suicidal thinking but was significantly increased in tho

273 confidence interval [CI], 2.58 to 3.36) and suicidal thoughts (odds ratio, 3.07; 95% CI, 2.25 to 4.1

274 38 (12%) of 310 participants with suicidal thoughts and 46 (12%) of 380 participants who h

275 sample included 456 adolescents who reported suicidal thoughts and 569 who reported non-suicidal self

276 tifying brain alterations that contribute to suicidal thoughts and behaviors (STBs) are important to

277 There is no definitive neural marker of suicidal thoughts and behaviors (STBs) or nonsuicidal se

278 irect observation and precise measurement of suicidal thoughts and behaviors and of the factors posit

279 cal study of risk and resilience factors for suicidal thoughts and behaviors, and their psychopatholo

280 of life and career history in understanding suicidal thoughts and behaviors.

281 ns between aspects of cannabis use, MDD, and suicidal thoughts and behaviours and examine whether suc

282 commonly cited as critical risk factors for suicidal thoughts and behaviours, it is unclear to what

283 ally significant, yet weak, risk factors for suicidal thoughts and behaviours.

284 f major depressive disorder (MDD) as well as suicidal thoughts and behaviours.

285 factors (i.e., longitudinal correlates) for suicidal thoughts and behaviours.

286 Suicidal thoughts and non-suicidal self-harm are common

287 ut was significantly increased in those with suicidal thoughts compared with those without, most robu

288 % of residents, and 4.5% reported having had suicidal thoughts during the past year.

289 the modified Maslach Burnout Inventory), and suicidal thoughts during the past year.

290 d Symptom Tracking scale) and SI (three-item suicidal thoughts factor of Concise Health Risk Tracking

291 activation (2.17 [1.34-3.00]; p<0.0001), and suicidal thoughts or attempts (0.61 [0.45-0.83]; p=0.001

292 days unable to work, behavioural activation, suicidal thoughts or attempts, intimate partner violence

293 Among participants with suicidal thoughts, the strongest predictors of transitio

294 Ketamine rapidly reduced suicidal thoughts, within 1 day and for up to 1 week in

295 ly women, and is associated with burnout and suicidal thoughts.

296 association of mistreatment with burnout and suicidal thoughts.

297 ailability between patients with and without suicidal thoughts.

298 ial withdrawal, unemployment, depression and suicidal thoughts.

299 al harassment) may contribute to burnout and suicidal thoughts.

300 searched, crossing the terms "suicide" and "suicidal" with each of the modern FDA-approved hypnotics